Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nonoxinol-9 2% gel
0703030G0AAAIAI
|
Nonoxinol 9 | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | 49 |
|
Nonoxinol-9 12.5% vaginal foam aerosol
0703030G0AAAEAE
|
Nonoxinol 9 | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nonoxinol-9 2% cream
0703030G0AAABAB
|
Nonoxinol 9 | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nonoxinol-9 5% pessaries
0703030G0AAAHAH
|
Nonoxinol 9 | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Nonoxinol-9 6% pessaries
0703030G0AAAGAG
|
Nonoxinol 9 | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.